Personal tools
Log in
You are here: Home About Leadership
Thomas Cech, the director of the BioFrontiers, is attracting talented researchers and students by providing an environment that encourages and rewards innovative thinking and collaborative research Today, BioFrontiers is attracting talented researchers and students by providing an environment that encourages and rewards innovative thinking and collaborative research.

The BioFrontiers Institute began in 2003 as the Colorado Initiative in Molecular Biotechnology; a grassroots effort to bridge traditional academic silos and encourage collaboration between scientists. Led by Nobel Laureate Thomas Cech, BioFrontiers is attracting talented researchers and students by providing an environment that encourages and rewards innovative thinking and collaborative research.

 

BioFrontiers Leadership

Thomas Cech

thomas cech

Director, BioFrontiers Institute

Distinguished Professor, Chemistry and Biochemistry

Investigator, Howard Hughes Medical Institute

Ph.D. University of California-Berkeley, Postdoc MIT

Thomas Cech discovered the principle of RNA catalysis, for which he was awarded the Nobel Prize in 1989. His recent discoveries include identifying and cloning genes for the catalytic subunit of telomerase and the proteins that cap off the ends of human chromosomes, which has significant implications for understanding and perhaps treating cancer and degenerative diseases.

Leslie Leinwand

tom cech

Chief Scientific Officer, BioFrontiers Institute

Professor, Molecular, Cellular and Developmental Biology with a joint appointment at the University of Colorado-Denver School of Medicine

Ph.D. Yale, Postdoc Rockefeller University

Leslie Leinwand studies hypertrophic cardiomyopathy and has discovered how heart disease in males and females can be fundamentally different at the molecular level. Her recent findings include how the same genetic background has different outcomes depending on gender and diet, helping to build a foundation for more personalized medicine.


Natalie Ahn

Natalie Ahn.jpg

Associate Director, BioFrontiers Institute

Professor, Chemistry and Biochemistry

Investigator, Howard Hughes Medical Institute

Ph.D. University of California-Berkeley, Postdoc Departments of Medicine and Pharmacology, University of Washington, Seattle

Natalie Ahn studies new mechanisms that cause cellular pathways to go awry in melanoma. An important aspect of her research is to develop and apply methods in proteomics and mass spectrometry, powerful technologies for mapping changes in proteins and their chemistries that occur in cancer on a global scale.

Kristi Anseth

kristi anseth

Associate Director, BioFrontiers Institute

Distinguished Professor, Chemical and Biological Engineering

Investigator, Howard Hughes Medical Institute

Ph.D. University of Colorado, Postdoc MIT

Kristi Anseth develops novel biomaterial systems for cell-based therapies with applications in regenerative medicine. Kristi Anseth's recent areas of interest include cartilage regeneration and discovery of biomaterial niches that promote wound healing.

Jana Watson-Capps

Jana.jpg

Associate Director, BioFrontiers Institute

Ph.D. Georgetown University

Jana Watson-Capps serves as chief-of-staff and head of strategy for BioFrontiers. She works with administrators, faculty, and students from across the CU system and external partners to develop and implement the institute's interdisciplinary programs and industrial partnerships.